JP2004503581A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004503581A5 JP2004503581A5 JP2002511717A JP2002511717A JP2004503581A5 JP 2004503581 A5 JP2004503581 A5 JP 2004503581A5 JP 2002511717 A JP2002511717 A JP 2002511717A JP 2002511717 A JP2002511717 A JP 2002511717A JP 2004503581 A5 JP2004503581 A5 JP 2004503581A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/617,328 US6458338B1 (en) | 1998-09-22 | 2000-07-17 | Amino acid stabilized medicinal aerosol formulations |
| PCT/US2000/042624 WO2002005784A1 (en) | 2000-07-17 | 2000-12-07 | A medicinal aerosol formulation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004503581A JP2004503581A (ja) | 2004-02-05 |
| JP2004503581A5 true JP2004503581A5 (US06573293-20030603-C00009.png) | 2005-11-17 |
Family
ID=24473199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002511717A Pending JP2004503581A (ja) | 2000-07-17 | 2000-12-07 | 医薬エアゾール製剤 |
Country Status (7)
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7014870B1 (en) * | 1992-11-06 | 2006-03-21 | Greystone Medical Group, Inc. | Compositions of oak bark extract related synthetic compositions and method of using same |
| GB9616237D0 (en) * | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
| US20040037898A1 (en) * | 1997-10-08 | 2004-02-26 | Hon David N.S | Compositions of oak bark extract, related synthetic compositions and method of using same |
| US7074388B2 (en) * | 1998-12-10 | 2006-07-11 | Kos Life Science, Inc. | Water stabilized medicinal aerosol formulation |
| AU2001278115A1 (en) * | 2000-08-04 | 2002-02-18 | Longwood Pharmaceutical Research, Inc. | Formulations of mometasone and a bronchodilator for pulmonary administration |
| US6787532B2 (en) * | 2000-08-05 | 2004-09-07 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivatives |
| US6858596B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| US6858615B2 (en) | 2002-02-19 | 2005-02-22 | Parion Sciences, Inc. | Phenyl guanidine sodium channel blockers |
| CA2518102C (en) * | 2003-03-04 | 2009-05-12 | Tanabe Seiyaku Co., Ltd. | Powdery preparation for nasal administration |
| US7745442B2 (en) | 2003-08-20 | 2010-06-29 | Parion Sciences, Inc. | Methods of reducing risk of infection from pathogens |
| US20060263350A1 (en) * | 2003-09-26 | 2006-11-23 | Fairfield Clinical Trials Llc | Combination antihistamine medication |
| US20060020035A1 (en) * | 2004-03-11 | 2006-01-26 | Oregon Health & Science University | Bone marrow protection with N-acetyl-L-cysteine |
| US8367734B1 (en) | 2005-08-11 | 2013-02-05 | Amphastar Pharmaceuticals Inc. | Stable epinephrine suspension formulation with high inhalation delivery efficiency |
| JP2009521481A (ja) * | 2005-12-21 | 2009-06-04 | ナイトロックス， エルエルシー | 安定なｓ−ニトロソチオール製剤 |
| US20080063722A1 (en) * | 2006-09-08 | 2008-03-13 | Advanced Inhalation Research, Inc. | Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI) |
| EP2170268A2 (en) * | 2007-06-25 | 2010-04-07 | Amgen, Inc. | Compositions of specific binding agents to hepatocyte growth factor |
| GB0801876D0 (en) * | 2008-02-01 | 2008-03-12 | Vectura Group Plc | Suspension formulations |
| TWI399202B (zh) | 2011-03-17 | 2013-06-21 | Intech Biopharm Ltd | 製備用於治療呼吸道疾病之定量噴霧吸入劑的製程方法 |
| AR086745A1 (es) | 2011-06-27 | 2014-01-22 | Parion Sciences Inc | 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida |
| GB201113662D0 (en) * | 2011-08-08 | 2011-09-21 | Prosonix Ltd | Pharmaceutical compositions |
| CA2869355A1 (en) * | 2012-04-11 | 2013-10-17 | Cipla Limited | Pharmaceutical composition |
| BR112015014178A2 (pt) | 2012-12-17 | 2017-07-11 | Parion Sciences Inc | compostos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil)carbamimidoil) pirazina-2- carboxamida |
| BR112015014349A2 (pt) | 2012-12-17 | 2017-07-11 | Parion Sciences Inc | derivados de cloro-pirazina carboxamida úteis para o tratamento de doenças favorecidas por hidratação mucosa insuficiente |
| US9102633B2 (en) | 2013-12-13 | 2015-08-11 | Parion Sciences, Inc. | Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds |
| WO2015120453A1 (en) * | 2014-02-10 | 2015-08-13 | University Of South Florida | Hormone treatment for age-related hearing loss-presbycusis |
| CN106137965A (zh) * | 2015-03-25 | 2016-11-23 | 天津金耀集团有限公司 | 一种含有环索奈德的气雾剂药物组合物 |
| CN106138014A (zh) * | 2015-03-25 | 2016-11-23 | 天津金耀集团有限公司 | 一种含有糖皮质激素的气雾剂药物组合物 |
| CN106137964A (zh) * | 2015-03-25 | 2016-11-23 | 天津金耀集团有限公司 | 一种含有丙酸倍氯米松的气雾剂药物组合物 |
| JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
| AU2017423862A1 (en) * | 2017-07-20 | 2020-02-06 | Aztherapies, Inc. | Powdered formulations of cromolyn sodium and ibuprofen |
| EP3668499A1 (en) | 2017-08-14 | 2020-06-24 | Axcella Health Inc. | Amino acid compositions for the treatment of liver disease |
| CN110302157B (zh) * | 2018-03-27 | 2023-01-17 | 天津金耀集团有限公司 | 一种异丙托溴铵气雾剂组合物及其制备方法 |
| EP3810123A1 (en) | 2018-06-20 | 2021-04-28 | Axcella Health Inc. | Compositions and methods for the treatment of fat infiltration in muscle |
| CN110755414A (zh) * | 2019-11-12 | 2020-02-07 | 南京华盖制药有限公司 | 一种酒石酸阿福特罗气雾剂及其制备方法 |
Family Cites Families (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE555319A (US06573293-20030603-C00009.png) | 1956-03-21 | 1900-01-01 | ||
| US2885427A (en) | 1956-11-15 | 1959-05-05 | Dow Chemical Co | Fluorination of trichloroethylene |
| US3261748A (en) | 1964-07-17 | 1966-07-19 | Dow Chemical Co | 1,1,1,2-tetrafluoroethane anesthetic |
| NL7708731A (nl) | 1976-08-13 | 1978-02-15 | Montedison Spa | Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen. |
| US4129603A (en) | 1978-02-07 | 1978-12-12 | Imperial Chemical Industries Limited | Manufacture of halogenated compounds |
| CA1136547A (en) | 1979-03-08 | 1982-11-30 | Song-Ling Lin | Aerosol anesthetic compositions |
| US5225183A (en) | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
| CA2050905A1 (en) | 1989-02-23 | 1990-08-24 | George R. Felt | Therapeutic aerosol formulations |
| US5439670A (en) | 1989-11-28 | 1995-08-08 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
| US5376386A (en) | 1990-01-24 | 1994-12-27 | British Technology Group Limited | Aerosol carriers |
| GB9001635D0 (en) | 1990-01-24 | 1990-03-21 | Ganderton David | Aerosol carriers |
| DE4003272A1 (de) * | 1990-02-03 | 1991-08-08 | Boehringer Ingelheim Kg | Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen |
| US5126123A (en) | 1990-06-28 | 1992-06-30 | Glaxo, Inc. | Aerosol drug formulations |
| US5190029A (en) | 1991-02-14 | 1993-03-02 | Virginia Commonwealth University | Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content |
| US5182097A (en) | 1991-02-14 | 1993-01-26 | Virginia Commonwealth University | Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content |
| PT656207E (pt) | 1991-06-10 | 2001-11-30 | Schering Corp | Formulacoes de aerossois sem clorofluorocarbonetos |
| JPH06508149A (ja) | 1991-06-10 | 1994-09-14 | シェリング・コーポレーション | クロロフルオロカーボン不含エーロゾル製剤 |
| JPH04366411A (ja) | 1991-06-13 | 1992-12-18 | Ngk Insulators Ltd | 薄膜磁気ヘッド |
| IL104068A (en) | 1991-12-12 | 1998-10-30 | Glaxo Group Ltd | Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant |
| JP3280974B2 (ja) | 1991-12-12 | 2002-05-13 | グラクソ、グループ、リミテッド | 医 薬 |
| US5744123A (en) | 1991-12-12 | 1998-04-28 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicaments |
| US5658549A (en) | 1991-12-12 | 1997-08-19 | Glaxo Group Limited | Aerosol formulations containing propellant 134a and fluticasone propionate |
| US5736124A (en) | 1991-12-12 | 1998-04-07 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicament |
| US5683676A (en) | 1991-12-12 | 1997-11-04 | Glaxo Group Limited | Canister containing aerosol formulations containing P134a and particulate medicaments |
| US5674471A (en) | 1991-12-12 | 1997-10-07 | Glaxo Group Limited | Aerosol formulations containing P134a and salbutamol |
| GB9202519D0 (en) | 1992-02-06 | 1992-03-25 | Glaxo Group Ltd | Medicaments |
| EP0630230B1 (en) | 1992-03-10 | 1996-12-04 | FISONS plc | Pharmaceutical inhalation compositions |
| WO1994021229A1 (en) | 1993-03-17 | 1994-09-29 | Minnesota Mining And Manufacturing Company | Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid |
| US5492688A (en) | 1993-04-28 | 1996-02-20 | The Center For Innovative Technology | Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent |
| ES2193186T3 (es) * | 1993-12-02 | 2003-11-01 | Abbott Lab | Composiciones medicamentosas en aerosol para la utilizacion con gases propulsores sin cfc. |
| DE69424181T2 (de) | 1993-12-20 | 2000-10-19 | Minnesota Mining & Mfg | Flunisolide aerosolformulierungen |
| US5594015A (en) | 1994-06-22 | 1997-01-14 | Regents Of The University Of California | Thiazolidine derivatives for the treatment of psoriasis |
| US5635159A (en) * | 1994-08-26 | 1997-06-03 | Abbott Laboratories | Aerosol drug formulations containing polyglycolyzed glycerides |
| GB9425160D0 (en) * | 1994-12-10 | 1995-02-08 | Glaxo Group Ltd | Medicaments |
| ATE236617T1 (de) * | 1994-12-22 | 2003-04-15 | Astrazeneca Ab | Aerosol-arzneiformulierungen |
| US5612053A (en) | 1995-04-07 | 1997-03-18 | Edward Mendell Co., Inc. | Controlled release insufflation carrier for medicaments |
| US5603918A (en) * | 1995-06-09 | 1997-02-18 | Boehringer Ingelheim Pharmaceuticals, Inc. | Aerosol composition of a salt of ipratropium and a salt of albuterol |
| US6193954B1 (en) | 1997-03-21 | 2001-02-27 | Abbott Laboratories | Formulations for pulmonary delivery of dopamine agonists |
| US5891420A (en) * | 1997-04-21 | 1999-04-06 | Aeropharm Technology Limited | Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation |
| US6129905A (en) * | 1997-04-21 | 2000-10-10 | Aeropharm Technology, Inc. | Aerosol formulations containing a sugar as a dispersant |
| US5891419A (en) * | 1997-04-21 | 1999-04-06 | Aeropharm Technology Limited | Environmentally safe flunisolide aerosol formulations for oral inhalation |
| US6136294C1 (en) * | 1998-09-22 | 2002-09-24 | Aeropharm Technology Inc | Amino acid stabilized medical aerosol formulation |
| US6586008B1 (en) * | 1999-08-25 | 2003-07-01 | Advanced Inhalation Research, Inc. | Use of simple amino acids to form porous particles during spray drying |
-
2000
- 2000-07-17 US US09/617,328 patent/US6458338B1/en not_active Expired - Fee Related
- 2000-12-07 MX MXPA03000442A patent/MXPA03000442A/es active IP Right Grant
- 2000-12-07 AU AU2001245190A patent/AU2001245190B2/en not_active Ceased
- 2000-12-07 EP EP00992655A patent/EP1301173A1/en not_active Withdrawn
- 2000-12-07 JP JP2002511717A patent/JP2004503581A/ja active Pending
- 2000-12-07 WO PCT/US2000/042624 patent/WO2002005784A1/en active IP Right Grant
- 2000-12-07 AU AU4519001A patent/AU4519001A/xx active Pending
- 2000-12-07 CA CA002416403A patent/CA2416403C/en not_active Expired - Fee Related
